연락처(단축번호):070-8262-1635
PubMed상의 PMID Number를 기재해주시면 더욱 빠른 서비스가 가능합니다.

N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1.
Trastuzumab emtansine for HER2-positive advanced breast cancer.
PMID:23020162

N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

J Clin Oncol. 2012 Sep 10;30(26):3234-41. doi: 10.1200/JCO.2011.40.5902. Epub 2012 May 29.
A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.
PMID:22649126


=====================================답변========================================
발송완료입니다.